Aware Super’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117M Sell
97,248
-2,170
-2% -$2.22M 1.65% 11
2026
Q1
$91.4M Buy
+99,418
New +$101M 1.39% 10
2025
Q3
$49.5M Sell
64,848
-4,356
-6% -$3.24M 0.68% 25
2025
Q2
$53.9M Sell
69,204
-2,086
-3% -$1.62M 0.79% 20
2025
Q1
$58.9M Buy
71,290
+3,889
+6% +$3.24M 1% 15
2024
Q4
$52M Buy
+67,401
New +$55.8M 0.83% 17
2023
Q4
$102M Buy
+95,124
New +$55.5M 1.37% 12

Other funds holding LLY

Aware Super's LLY Position: Q2 2026 in Review

Aware Super reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $2.22M and leaving 97,248 shares worth $117M. The position accounts for 1.65% of the portfolio, ranked #11.

Aware Super first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aware Super held 97,248 shares of Eli Lilly worth $117M as of Q2 2026.
  • Aware Super sold 2,170 Eli Lilly shares in Q2 2026, an estimated $2.22M.
  • Eli Lilly made up 1.65% of Aware Super's portfolio in Q2 2026, its #11 holding.
  • Aware Super first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.